PUMA BIOTECHNOLOGY INC shareholders Q2 2023

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 70 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

PUMA BIOTECHNOLOGY INC shareholders Q2 2023
NameSharesValueWeighting ↓
Geneos Wealth Management Inc. 1,000$3,5300.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 19,453$68,6690.00%
Cutler Group LLC / CA 200$00.00%
TUCKER ASSET MANAGEMENT LLC 126$4450.00%
JPMORGAN CHASE & CO 1,103$3,8940.00%
Impact Partnership Wealth, LLC 308$1,0870.00%
BARCLAYS PLC 17,340$610.00%
COMMONWEALTH EQUITY SERVICES, LLC 10,749$380.00%
ROYAL BANK OF CANADA 988$3,0000.00%
VANGUARD GROUP INC 3,764,131$13,287,3830.00%
UBS Group AG 4,060$14,3320.00%
RHUMBLINE ADVISERS 2,086$7,3630.00%
PRUDENTIAL FINANCIAL INC 16,400$57,8920.00%
BNP PARIBAS FINANCIAL MARKETS 242$8540.00%
OSAIC HOLDINGS, INC. 16,214$51,9350.00%
FMR LLC 63,918$225,6310.00%
DIMENSIONAL FUND ADVISORS LP 430,308$1,518,9870.00%
US BANCORP \DE\ 200$7060.00%
FRANKLIN RESOURCES INC 24,234$85,5460.00%
BANK OF AMERICA CORP /DE/ 32,904$116,1510.00%
External links

This page lists PUMA BIOTECHNOLOGY INC's shareholders in Q2 2023. To view PUMA BIOTECHNOLOGY INC's shareholder history, click here.